These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24403315)

  • 1. Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice.
    Kita T; Yamashita T; Sasaki N; Kasahara K; Sasaki Y; Yodoi K; Takeda M; Nakajima K; Hirata K
    Cardiovasc Res; 2014 Apr; 102(1):107-17. PubMed ID: 24403315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
    Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
    Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
    Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
    Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice.
    Steffens S; Burger F; Pelli G; Dean Y; Elson G; Kosco-Vilbois M; Chatenoud L; Mach F
    Circulation; 2006 Oct; 114(18):1977-84. PubMed ID: 17043169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L
    Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response.
    Kasahara K; Sasaki N; Yamashita T; Kita T; Yodoi K; Sasaki Y; Takeda M; Hirata K
    J Am Heart Assoc; 2014 Apr; 3(2):e000719. PubMed ID: 24755152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
    Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
    J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression.
    Sharma M; Schlegel MP; Afonso MS; Brown EJ; Rahman K; Weinstock A; Sansbury BE; Corr EM; van Solingen C; Koelwyn GJ; Shanley LC; Beckett L; Peled D; Lafaille JJ; Spite M; Loke P; Fisher EA; Moore KJ
    Circ Res; 2020 Jul; 127(3):335-353. PubMed ID: 32336197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of natural CD4+CD25+ T regulatory cells with anti-CD25 antibody does not change the course of Pseudomonas aeruginosa-induced acute lung infection in mice.
    Carrigan SO; Yang YJ; Issekutz T; Forward N; Hoskin D; Johnston B; Lin TJ
    Immunobiology; 2009; 214(3):211-22. PubMed ID: 19215803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis.
    Notley CA; McCann FE; Inglis JJ; Williams RO
    Arthritis Rheum; 2010 Jan; 62(1):171-8. PubMed ID: 20039431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
    Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
    Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells restrain CD4+ T cells from causing unregulated immune activation and hypersensitivity to lipopolysaccharide challenge.
    Okeke EB; Okwor I; Uzonna JE
    J Immunol; 2014 Jul; 193(2):655-62. PubMed ID: 24943218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amygdalin mediates relieved atherosclerosis in apolipoprotein E deficient mice through the induction of regulatory T cells.
    Jiagang D; Li C; Wang H; Hao E; Du Z; Bao C; Lv J; Wang Y
    Biochem Biophys Res Commun; 2011 Aug; 411(3):523-9. PubMed ID: 21756879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine.
    Wigren M; Kolbus D; Dunér P; Ljungcrantz I; Söderberg I; Björkbacka H; Fredrikson GN; Nilsson J
    J Intern Med; 2011 May; 269(5):546-56. PubMed ID: 21114693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney.
    Zhang JL; Sun DJ; Hou CM; Wei YL; Li XY; Yu ZY; Feng JN; Shen BF; Li Y; Xiao H
    Transpl Immunol; 2010 Oct; 24(1):17-25. PubMed ID: 20850528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+ T cell depletion impairs tolerance induction in a murine model of asthma.
    Boudousquié C; Pellaton C; Barbier N; Spertini F
    Clin Exp Allergy; 2009 Sep; 39(9):1415-26. PubMed ID: 19624523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of TCR/CD3 complex CD3{varepsilon} chains of regulatory CD4+ T (Treg) lymphocytes: role in Treg differentiation in vitro and impact on Treg in vivo.
    Rojo JM; Ojeda G; Acosta YY; Montes-Casado M; Criado G; Portolés P
    J Leukoc Biol; 2014 Mar; 95(3):441-50. PubMed ID: 24212096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The enhancing effect of "Xuebijing injection" on lipopolysaccharide-induced apoptosis of regulatory T cells and mediation of polarization of helper T cells].
    Dai XG; Yao YM; Ai YH; Yu Y
    Zhonghua Shao Shang Za Zhi; 2009 Apr; 25(2):106-10. PubMed ID: 19799034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.